Search company, investor...

Founded Year



Debt - VI | Alive

Total Raised


Last Raised

$2M | 1 yr ago

About CirculoGene Diagnostics

CirculoGene Diagnostics is a molecular diagnostics company operating in the healthcare industry. The company offers a comprehensive blood-based approach to detecting clinically significant tumor DNA/RNA alterations, aiding oncologists in personalizing and monitoring patient treatment plans. Its services primarily cater to the healthcare and medical industry. CirculoGene Diagnostics was formerly known as CirculoGene Theranostics, LLC. It was founded in 2015 and is based in Birmingham, Alabama.

Headquarters Location

3125 Independence Drive Suite 301

Birmingham, Alabama, 35209,

United States




Expert Collections containing CirculoGene Diagnostics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

CirculoGene Diagnostics is included in 2 Expert Collections, including Digital Health.


Digital Health

10,804 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.


Oncology Tech

457 items

This collection includes companies applying technology to cancer care, diagnosis, and treatment. Examples include vendors offering cancer detection and diagnosis, oncology clinical decision support, real-world data, and AI oncology drug discovery.

CirculoGene Diagnostics Patents

CirculoGene Diagnostics has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Molecular biology, Oncology, Genetics, Biotechnology, DNA


Application Date


Grant Date



Related Topics

Molecular biology, Oncology, Genetics, Biotechnology, DNA



CirculoGene Diagnostics Frequently Asked Questions (FAQ)

  • When was CirculoGene Diagnostics founded?

    CirculoGene Diagnostics was founded in 2015.

  • Where is CirculoGene Diagnostics's headquarters?

    CirculoGene Diagnostics's headquarters is located at 3125 Independence Drive, Birmingham.

  • What is CirculoGene Diagnostics's latest funding round?

    CirculoGene Diagnostics's latest funding round is Debt - VI.

  • How much did CirculoGene Diagnostics raise?

    CirculoGene Diagnostics raised a total of $11.38M.

  • Who are the investors of CirculoGene Diagnostics?

    Investors of CirculoGene Diagnostics include Paycheck Protection Program.

  • Who are CirculoGene Diagnostics's competitors?

    Competitors of CirculoGene Diagnostics include Genomic Health and 2 more.


Compare CirculoGene Diagnostics to Competitors

20/20 GeneSystems Logo
20/20 GeneSystems

20/20 GeneSystems is a company focused on modernizing clinical lab testing, primarily in the healthcare and biotechnology sectors. The company offers diagnostic tests that aid in the fight against cancer and COVID-19, utilizing machine learning and real-world data to provide comprehensive testing services. Their main offerings include a blood test that combines the results of multiple cancer biomarker tests to calculate a probability score for different types of cancers, and a range of COVID-19 testing services. It is based in Rockville, Maryland.

OncoTAB Logo

OncoTAB is a biotechnology company focused on improving the quality of cancer care. The company's main offering is a non-invasive blood test that aids in the detection of breast cancer in women with dense breast tissue. OncoTAB primarily serves the healthcare industry. It is based in Charlotte, North Carolina.

Freenome Logo

Freenome serves as a biotechnology company focused on early cancer detection through advanced diagnostic tools. The company develops blood tests that identify early signs of cancer by analyzing biomarkers from tumor and non-tumor sources using a multiomics platform. These tests are designed to be non-invasive and accessible, aiming to detect various types of cancer at its most treatable stages. It was founded in 2014 and is based in South San Francisco, California.

Owlstone Medical Logo
Owlstone Medical

Owlstone Medical is a diagnostics company developing a breathalyzer for disease detection. It offers a breath biopsy platform to enable early detection across multiple cancers and other related conditions. The company was founded in 2004 and is based in Cambridge, U.K.


Accuragen is a company focused on the development of cancer diagnostics technology in the healthcare sector. The company's main service is the development of liquid biopsy technology, which is a non-invasive alternative to tissue biopsy, used for DNA and RNA sequencing to determine a patient's optimal treatment plan. Accuragen primarily sells to the healthcare industry, specifically in the field of cancer treatment. It is based in Menlo Park, California.

Auspex Diagnostics

Auspex Diagnostics provides artificial intelligence (AI) based advanced cancer diagnostics services intended to improve the quality of cancer care. The company's machine learning (ML) algorithm analyzes the genomic information of a patient's tumor sample and accurately assesses the risk of recurrence and drug efficacy, enabling the oncologists and patients to make the optimal data-driven decisions and personalize the treatment plan. It was founded in 2012 and is based in Warren, New Jersey.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.